Bio-Path Holdings, Inc. (BPTH)
Develops experimental cancer drugs using DNA-based nanoparticles to attack tumor cells.
$0.04+0.05%Healthcare
StockGlow Score
Leaning Bearish
BearishBullish
1 year ago-73.3%
The outlook
Bio-Path Holdings trades at $0.04, sitting near its 52-week low with mixed momentum against its moving averages. Analyst coverage appears thin. The overall data leans bearish, reflecting the stock's position in the lower part of its recent range.
What’s behind the score
Price trendMixed vs its moving averages
52-week range21% of the way from its 52-week low to high
Market cap
$2.0M
52-wk high
$0.15
52-wk low
$0.01
50-day avg
$0.04
200-day avg
$0.06
Trailing P/E
—